Does Insurance Cover Spravato?

Spravato has FDA-approved labeling for two adult indications and is administered in a certified healthcare setting under a REMS program. [FDA label] Approved products with defined indications are the category insurers most commonly build coverage policies around, which is why Spravato typically has a written policy rather than a blanket exclusion.

Having a policy is not the same as being covered. A policy usually sets conditions — diagnosis, prior treatment history, prescriber and setting requirements, and an authorization period.

Spravato sits awkwardly between the two: it is a drug, but it is administered in a clinic and never dispensed to the patient. Different plans resolve that differently. Some cover it under the medical benefit as a provider-administered drug. Others require it to be supplied by a specialty pharmacy to the treatment setting under the pharmacy benefit.

The distinction matters because it determines which deductible and cost-sharing rules apply, which authorization process is used, and sometimes which phone number you need to call. Ask your plan explicitly which benefit applies.

Prior authorization is standard for Spravato. It is a review against the plan’s written criteria, submitted by the clinic with supporting clinical documentation, and it happens before treatment rather than after.

The process, documentation, approval periods, renewals, and appeals are covered in detail in Spravato prior authorization: a patient guide.

Requirements are plan-specific, but requests generally fall into recognizable categories:

Diagnosis

• A documented diagnosis of major depressive disorder, with the diagnosis codes the plan requires.
• Documentation of the current episode, and often a symptom severity measure.

Prior medication trials

• The specific antidepressants tried, usually during the current episode.
• Dose reached and duration at that dose, to establish an adequate trial.
• The outcome — inadequate response, or intolerance.

Treatment setting and prescriber

• Confirmation that treatment will occur in a REMS-certified healthcare setting.
• Prescriber information, and for some plans a required specialty.

This is why medication history comes up repeatedly. The same records that support the clinical evaluation described in who qualifies for Spravato usually support the authorization request.

Even with coverage approved, what you pay depends on your plan’s cost sharing:

• Deductible — the amount you pay for covered services before your plan begins to pay. [HealthCare.gov]
• Coinsurance — a percentage of the cost you pay after meeting the deductible. [HealthCare.gov]
• Copayment — a fixed amount per service or prescription. [HealthCare.gov]
• Out-of-pocket maximum — the most you pay in a plan year, after which the plan generally covers 100% of covered benefits. [HealthCare.gov]

Two structural factors matter as much as the percentages. First, treatment is repeated: twice-weekly sessions during induction mean cost sharing recurs rather than happening once. Second, network status affects the rate your plan applies and, in some plans, whether services are covered at all.

Because these are plan-specific, this page gives no dollar figures and no promises about affordability. Ask your insurer for an estimate.

The manufacturer publishes information about patient support and affordability programs associated with Spravato. [Manufacturer] Programs of this kind typically have their own eligibility rules, benefit limits, enrollment steps, and expiration terms, and commonly exclude patients whose coverage is through a government program such as Medicare or Medicaid.

This page describes such programs only in general terms because their details change and are set by the manufacturer, not by any clinic. Check the current program materials directly, and confirm eligibility before assuming a benefit applies.

“Does insurance cover Spravato?” has no single answer because “insurance” is not one entity. Coverage differs by insurer, and it also differs between plans from the same insurer — an employer-sponsored plan, a marketplace plan, and a Medicare Advantage plan from one company can each treat it differently.

Sources of variation include:

• the plan's written medical policy and its criteria;
• whether the drug falls under the medical or pharmacy benefit;
• formulary placement and any specialty pharmacy requirement;
• network status of the treating clinic and prescriber;
• state requirements and plan type;
• the length of the authorization period and renewal rules.

Calling the member services number on your insurance card and asking these questions will produce more useful information than any general article can:

• Is Spravato (esketamine) covered under my plan, and under the medical or pharmacy benefit?
• Is prior authorization required, and what clinical criteria apply?
• How many documented antidepressant trials does the policy require, and at what dose and duration?
• Must the medication be supplied through a specific specialty pharmacy?
• What will my cost be per session — deductible, coinsurance or copay?
• How much of my deductible and out-of-pocket maximum have I met this plan year?
• How long is an authorization valid, and what is required to renew it?
• Is the clinic and prescriber I plan to use in network for this service?
• If a request is denied, what is the appeals process and the deadline?

Ask for a reference number for the call, and note the date and the representative’s name.

Spravato is frequently covered, but coverage is conditional. Expect prior authorization, expect your plan to ask for documented treatment history and specific diagnosis coding, and expect the benefit type — medical or pharmacy — to shape how billing works.

The variables that determine what you actually pay are all plan-specific: deductible, coinsurance or copay, network status, and out-of-pocket maximum. The only reliable way to get numbers is to ask your insurer, using the questions listed above.